Do States Like Telehealth? – Telehealth Crash Course Webinar SeriesEpstein Becker Green
Telehealth has gone mainstream. As technology becomes more sophisticated and clinicians find innovative ways to provide services, the various applications of telehealth are taking on new dimensions. The trend toward telehealth is being driven by employers, private insurers, clinicians, and technology companies. The trend notwithstanding, serious legal and regulatory issues remain and will be a barrier to the wider adoption of telehealth. With the significant attention that recent litigation and enforcement activities in certain states have received, many view state laws and policies as the biggest impediment to the wider adoption of telehealth.
In the second installment of EBG’s Telehealth Crash Course series, we will discuss recent legal and regulatory developments in the states related to telehealth and the various initiatives underway to facilitate greater adoption of telehealth. Additionally, we will address issues such as multistate provider licensure, scope of practice, prescribing, and recently introduced state telehealth-related bills.
Epstein Becker Green Webinar - Presented by Rene Quashie on 9/15/2015.
http://www.ebglaw.com/ren%C3%A9-y-quashie/events/do-states-like-telehealth-telehealth-crash-course-webinar-series/
These materials have been provided for informational purposes only and are not intended and should not be construed to constitute legal advice. The content of these materials is copyrighted to Epstein Becker & Green, P.C. ATTORNEY ADVERTISING.
How Will My Organization Absorb the Influx of New Patients? – Telehealth Cras...Epstein Becker Green
The implementation of the Affordable Care Act (“ACA”) has forced U.S. health care organizations to think about how best to position themselves to take advantage of such a massive change. It has been estimated that the ACA will expand coverage to approximately 32 million individuals lawfully present in the United States. At the same time, the United States’ rapidly increasing aging population will account for an additional 15 more million seniors covered by Medicare. This incredible influx of elderly and newly insured patients is forcing an already overly burdened U.S. health care system to utilize and implement policies to adequately handle this expanded patient population. But how will health care organizations absorb this radical increase in potential patients? Many are exploring telehealth/telemedicine options as an integral component of their treatment paradigm. They also need to address where the additional health care professionals will come from if the United States is not producing sufficient numbers.
In the final installment of EBG’s Telehealth Crash Course series, we will explore the potential health care immigration issues that employers should be aware of, as well as immigrant options that are available to help health care organizations recruit the foreign talent required to keep pace with a changing landscape.
Epstein Becker Green Webinar - Presented by Kimberly N. Grant
http://www.ebglaw.com/kimberly-n-grant/events/how-will-my-organization-absorb-the-influx-of-new-patients-telehealth-crash-course-webinar-series/
These materials have been provided for informational purposes only and are not intended and should not be construed to constitute legal advice. The content of these materials is copyrighted to Epstein Becker & Green, P.C. ATTORNEY ADVERTISING.
This course provides training and CEUs for addicitons counselors and LPCs working in Addictions, Mental Health and Co-Occurring Disorders will help counselors, social workers, marriage and family therapists, alcohol and drug counselors and addictions professionals get continuing education and certification training to aid them in providing services guided by best practices. AllCEUs is approved by the california Association of Alcohol and Drug Abuse Counselors (CAADAC), NAADAC, the Association for Addictions Professionals, the Alcohol and Drug Abuse Counseling Board of Georgia (ADACB-GA), the National Board for Certified Counselors (NBCC) and most states.
A recent legal decision in New Mexico could adversely affect Texas physicians and New Mexico patients. This presentation discusses how this new issue is reminiscent of pre-tort reform years and what TMLT is doing to help.
National Health Care Reform: The Proposals and the Politicssoder145
Presentation by Elizabeth Lukanen at the University of Minnesota Academic Health Center's Student Leadership Summit in Minneapolis, MN, December 5, 2009.
An increasing number of states are expanding managed care. This webinar provides a straightforward overview and history of the Medicaid Managed Care program and how it applies to physicians, practices, and patients.
Do States Like Telehealth? – Telehealth Crash Course Webinar SeriesEpstein Becker Green
Telehealth has gone mainstream. As technology becomes more sophisticated and clinicians find innovative ways to provide services, the various applications of telehealth are taking on new dimensions. The trend toward telehealth is being driven by employers, private insurers, clinicians, and technology companies. The trend notwithstanding, serious legal and regulatory issues remain and will be a barrier to the wider adoption of telehealth. With the significant attention that recent litigation and enforcement activities in certain states have received, many view state laws and policies as the biggest impediment to the wider adoption of telehealth.
In the second installment of EBG’s Telehealth Crash Course series, we will discuss recent legal and regulatory developments in the states related to telehealth and the various initiatives underway to facilitate greater adoption of telehealth. Additionally, we will address issues such as multistate provider licensure, scope of practice, prescribing, and recently introduced state telehealth-related bills.
Epstein Becker Green Webinar - Presented by Rene Quashie on 9/15/2015.
http://www.ebglaw.com/ren%C3%A9-y-quashie/events/do-states-like-telehealth-telehealth-crash-course-webinar-series/
These materials have been provided for informational purposes only and are not intended and should not be construed to constitute legal advice. The content of these materials is copyrighted to Epstein Becker & Green, P.C. ATTORNEY ADVERTISING.
How Will My Organization Absorb the Influx of New Patients? – Telehealth Cras...Epstein Becker Green
The implementation of the Affordable Care Act (“ACA”) has forced U.S. health care organizations to think about how best to position themselves to take advantage of such a massive change. It has been estimated that the ACA will expand coverage to approximately 32 million individuals lawfully present in the United States. At the same time, the United States’ rapidly increasing aging population will account for an additional 15 more million seniors covered by Medicare. This incredible influx of elderly and newly insured patients is forcing an already overly burdened U.S. health care system to utilize and implement policies to adequately handle this expanded patient population. But how will health care organizations absorb this radical increase in potential patients? Many are exploring telehealth/telemedicine options as an integral component of their treatment paradigm. They also need to address where the additional health care professionals will come from if the United States is not producing sufficient numbers.
In the final installment of EBG’s Telehealth Crash Course series, we will explore the potential health care immigration issues that employers should be aware of, as well as immigrant options that are available to help health care organizations recruit the foreign talent required to keep pace with a changing landscape.
Epstein Becker Green Webinar - Presented by Kimberly N. Grant
http://www.ebglaw.com/kimberly-n-grant/events/how-will-my-organization-absorb-the-influx-of-new-patients-telehealth-crash-course-webinar-series/
These materials have been provided for informational purposes only and are not intended and should not be construed to constitute legal advice. The content of these materials is copyrighted to Epstein Becker & Green, P.C. ATTORNEY ADVERTISING.
This course provides training and CEUs for addicitons counselors and LPCs working in Addictions, Mental Health and Co-Occurring Disorders will help counselors, social workers, marriage and family therapists, alcohol and drug counselors and addictions professionals get continuing education and certification training to aid them in providing services guided by best practices. AllCEUs is approved by the california Association of Alcohol and Drug Abuse Counselors (CAADAC), NAADAC, the Association for Addictions Professionals, the Alcohol and Drug Abuse Counseling Board of Georgia (ADACB-GA), the National Board for Certified Counselors (NBCC) and most states.
A recent legal decision in New Mexico could adversely affect Texas physicians and New Mexico patients. This presentation discusses how this new issue is reminiscent of pre-tort reform years and what TMLT is doing to help.
National Health Care Reform: The Proposals and the Politicssoder145
Presentation by Elizabeth Lukanen at the University of Minnesota Academic Health Center's Student Leadership Summit in Minneapolis, MN, December 5, 2009.
An increasing number of states are expanding managed care. This webinar provides a straightforward overview and history of the Medicaid Managed Care program and how it applies to physicians, practices, and patients.
Medical State Boards are political bodies. This presentation outlines challenges in implementing policy with, oftentimes, dysfunctional politics and poor leadership especially as it relates to physician issues. Competency issues are difficult to adjudicate on and expert opinion (the "hired guns") do not make the process any more effective. Institutional bias ends up being the basis for decision making.
ReferencesConclusionThe capacity to adapt is crucial.docxlorent8
References
Conclusion
The capacity to adapt is crucial in an era of rapid change. Today’s politically astute nurses have many opportunities to shape public policy, by working in coalition together and with other health professionals and consumers, and to advocate for state and federal health policies and regulations that will allow the public greater access to affordable, quality health care. The window of opportunity that opened with the enactment of the comprehensive ACA will look somewhat different as we move forward. It is essential for nurses and APRNs to develop skills to capitalize on the chaos present in the healthcare and political environments and to create opportunities to advance the profession as a whole. Familiarity with the regulatory process will give nurses and APRNs the tools needed to navigate this dynamic environment with confidence. Knowing how to monitor the status of critical issues involving scopes of practice, licensure, and reimbursement will allow APRNs to influence the outcomes of debates on those issues. Participation in specialty professional nurse organizations is especially advantageous. Participation builds a membership base, providing the foundation for strong coalition building and a power base from which to effect change in the political and regulatory arenas. Participation also gives members ready access to a network of colleagues, legislative affairs information, and professional and educational opportunities. Although supporting the profession through participation is central, it is equally important to remember that each professional nurse has the ability to make a difference.
Discussion Points
Compare and contrast the legislative and regulatory processes. Describe the major methods of credentialing. List the benefits and weaknesses of each method from the standpoint of public protection and protection of the professional scope of practice. Discuss the role of state BONs in regulating professional practice. Obtain a copy of a proposed or recently promulgated regulation. Using the questions in Exhibit 4-1, analyze the regulation for its impact on nursing practice. Describe the federal government’s role in the regulation of health professions. To what extent do you believe this role will increase or decrease over time? Explain your rationale. Analyze the pros and cons of multistate regulation (choose multistate regulation of RNs, APRNs, or a combination). Based on your analysis, develop and defend a position either for or against multistate regulation. Prepare written testimony for a public hearing defending or opposing the need for a second license for APRNs. Contrast the BON and the national or state nurses association vis-à-vis mission, membership, authority, functions, and source of funding. Identify a proposed regulation. Discuss the current phase of the process, identify methods for offering comments, and submit written comments to the administrative agency. Evaluate the APRN section of the nu.
Working with Regulators: A Focus on CMS | Took Kit: A Guide for Patient AdocatesCancerSupportComm
The Affordable Care Act (ACA) is the tip of a very large, multi-faceted iceberg, one that is moving inexorably forward and will result in broad, deep changes in the way that health care in this country is understood and delivered. These changes are already exerting a significant impact on cancer research and care, and will continue to do so for the foreseeable future. This is also an era in which the patient voice and genuine, active patient participation have become integral to the process of developing and implementing biomedical research and health care policy.
That process is complex and multidimensional—but also well defined and transparent. The ability to influence the outcomes requires that an organization have a working knowledge of how the process works, which agencies are responsible and who makes the decisions. It is also critical to understand the ways in which electoral politics at both the national and state level impact health care policy. While that sounds straightforward, the regulatory process often can appear impenetrable to the organizations who seek to make their voices heard and influence the outcomes.
This Tool Kit is intended as a practical guide for patient advocacy organizations in their efforts to educate themselves about the regulatory process, develop appropriate staff expertise and responsibility for this area, and ultimately make a difference.
Regulatory Compliance, Risk Management, and the Trustee's RolePYA, P.C.
PYA Principal Shannon Sumner and Consulting Manager Susan Thomas presented “Regulatory Compliance, Risk Management, and the Trustee’s Role.” In this presentation, they will:
Describe the evolving compliance and risk management landscape, including government agencies’ expectations for compliance oversight. This presentation will:
- Outline recent government investigations and settlements.
- Provide key takeaways regarding responsibilities for ensuring an effective compliance program.
- Connect trustee duties to specific elements of enterprise risk management.
- Empower trustees with questions to ask leadership teams in preparation for playing a more active role in the compliance program.
This paper should be double spaced and be 4-6 pages in 12 point New .docxdivinapavey
This paper should be double spaced and be 4-6 pages in 12 point New Times Roman font. Include a cover page [not counted as a page] which should have student name and title of your paper. Must have at end of the paper a list of references in APA Format [not counted as a page]. No deduction if paper exceeds a page or so. But deduction of 2 points from the 25pts paper is worth if paper is less than 4 pages. The paper is to be posted in Assignment #4 drop box. Paper should be submitted in word doc. No pdf papers as I cannot post my comments in your paper.
Paper must be submitted by last day of class. No late papers accepted after last day of class.
The final project for this course is an analysis of the legal and ethical issues involved in the below health care scenario.
A 72 year old woman was admitted to the Neurological Intensive Care Unit following a cerebral hemorrhage which left her with severe brain damage and ventilator dependent. One year before this event, the patient and her husband had drawn up "living wills" with an attorney. She was diagnosed by her treating physician as being in a permanent unconscious condition. The patient's living will specified that the patient did not want ventilator support or other artificial life support in the event of a permanent unconscious condition or terminal condition.
The patient's husband is her legal next of kin and the person with surrogate decision-making authority. When the living will was discussed with him, he insisted that the patient had not intended for the document to be used in a situation like the present one. Further discussion with him revealed that he understood that the patient would not be able to recover any meaningful brain function but he argued that the living will did not apply because her condition was not imminently terminal. He further indicated that he did not consider his wife to be in a permanent unconscious condition. The immediate family members (the couple’s adult children) disagreed with their father’s refusal to withdraw life support.
The treatment team allowed a week to pass to allow the husband more time to be supported in his grief and to appreciate the gravity of his wife’s situation. Nevertheless, at the end of this time, the husband was unwilling to authorize withdrawal of life support measures consistent with the patient's wishes as expressed in her living will.
List and discuss the three most important ethical/legal issues in this scenario [Just three]. Why are they legal /ethical issues? Be sure and define the concepts you discuss. As a health care provider, how would you have handled this situation and why?
Use as headings in your paper the three legal/ethics issues you pick to discuss.
You are on the honor system not to discuss or consult with any students or other individuals about this paper. You may use the information we have discussed in the class, the articles in the class, and the article I have furnished below
but you may NOT do internet r.
This paper should be double spaced and be 6-8 pages in 12 point New .docxdivinapavey
This paper should be double spaced and be 6-8 pages in 12 point New Times Roman font. Include a cover page [not counted as a page] which should have student name and title of your paper. Must have at end of the paper a list of references in APA Format [not counted as a page]. No deduction if paper exceeds a page or so. But deduction of 2 points from the 25pts paper is worth if paper is less than 4 pages. The paper is to be posted in Assignment #4 drop box. Paper should be submitted in word doc. No pdf papers as I cannot post my comments in your paper.
Paper must be submitted by last day of class. No late papers accepted after last day of class.
The final project for this course is an analysis of the legal and ethical issues involved in the below health care scenario.
A 72 year old woman was admitted to the Neurological Intensive Care Unit following a cerebral hemorrhage which left her with severe brain damage and ventilator dependent. One year before this event, the patient and her husband had drawn up "living wills" with an attorney. She was diagnosed by her treating physician as being in a permanent unconscious condition. The patient's living will specified that the patient did not want ventilator support or other artificial life support in the event of a permanent unconscious condition or terminal condition.
The patient's husband is her legal next of kin and the person with surrogate decision-making authority. When the living will was discussed with him, he insisted that the patient had not intended for the document to be used in a situation like the present one. Further discussion with him revealed that he understood that the patient would not be able to recover any meaningful brain function but he argued that the living will did not apply because her condition was not imminently terminal. He further indicated that he did not consider his wife to be in a permanent unconscious condition. The immediate family members (the couple’s adult children) disagreed with their father’s refusal to withdraw life support.
The treatment team allowed a week to pass to allow the husband more time to be supported in his grief and to appreciate the gravity of his wife’s situation. Nevertheless, at the end of this time, the husband was unwilling to authorize withdrawal of life support measures consistent with the patient's wishes as expressed in her living will.
List and discuss the three most important ethical/legal issues in this scenario [Just three]. Why are they legal /ethical issues? Be sure and define the concepts you discuss. As a health care provider, how would you have handled this situation and why?
Use as headings in your paper the three legal/ethics issues you pick to discuss.
You are on the honor system not to discuss or consult with any students or other individuals about this paper. You may use the information we have discussed in the class, the articles in the class, and the article I have furnished below
but you may NOT do internet r.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
2. Influencing the Introduction of a Bill
Nurses can influence as constituents and as members of
professional organizations that lobby congress.
Organized groups such as the ANA, AACN, CNA
What can nurses do?
3. Committee Action
Centers for policy making at federal and
state levels
Conflicting points of view discussed and
legislation refined or amended
Organization, consensus building, and
time
15% of bills that go through committees
are reported out to the House or Senate
4. Conference Committee
A type of joint committee
(House and Senate)
Work together to address
differences
5. Ways a committee can handle a bill
Approve a bill with or without
amendments
Rewrite or revise a bill, and report it out
to the full House or Senate
Report it unfavorable (i.e., allow the bill to
be considered by the full House or
Senate, but with a recommendation that
it be rejected)
Take no action, which kills the bill
6. Authorization and Appropriation Process
Important for nurses to be familiar with this process
Nurse Education Act
Scholarships for the Disadvantaged Students
National Institutes of Nursing Research
7. Authorization and Appropriation Process
Two Step Process
1. Authorization Bill
* Establishes the purpose of and sets guidelines
for the program
* Legal authority
2. Appropriation Bill
* Allows an agency or program to
spend money
9. Presidential Appointments
Approved by the Senate
Described in the U.S. Constitution Supreme Court Nominees
High-level positions
Ambassadors
Federal Judges
U.S. Attorneys
U.S. Marshalls
10. Regulatory Process
Major role is to interpret the laws
Important for nurses to influence the
regulatory process
Regulations have a direct impact on
nurses’ work and professional life
11. Sources of Regulation Affecting Nursing Practice
Nursing Boards
Authority through state laws
What is determined at the state level?
Initial qualifications for licensure
Continuing educational requirements
Disciplinary procedures
Complaint resolution processes
Professional misconduct
Mandatory reporting requirements
Specific scopes of practice
12. Sources of Regulation Affecting Nursing Practice
Health and Human Services
HHS Regulations
Civil Rights, Privacy, Food and Drug Safety,
MCR/MCD programs, health care fraud,
medical research, technology standards,
and tribal matters
Umbrella organization for...
CMS, FDA, CDC, and OCR
13. Sources of Regulation Affecting Nursing Practice
Centers for Medicare and Medicaid
Government health insurance
Medicare versus Medicaid
Office of Inspector General
List of Excluded Individuals/Entities
14. Sources of Regulation Affecting Nursing Practice
The Joint Commission
Compliance with MCR/MCD
Standards
Goal
15. Sources of Regulation Affecting Nursing Practice
Federal, State, and Local Law
Public Health Codes
Emergency preparedness
Communicable diseases
Environmental controls
Utilization of health care facilities
Staff credentials and competency
Policies and procedures
Sanitation, Housing, Childhood nutrition
Mental health issues, Food safety
Other elements related to nursing care
16. Sources of Regulation Affecting Nursing Practice
Organizational Policy
Nurse responsibility
Practice Standards
Standardization and Consistency
Failure to follow
17. Scope of Practice
Scope of practice has evolved and expanded
Issues with scope of practice
Medical societies challenging BON
Actions by the AMA and degrading terms
